<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-0319</journal-id>
<journal-title><![CDATA[Revista Cubana de Enfermería]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Enfermer]]></abbrev-journal-title>
<issn>0864-0319</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-03192019000300016</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Hipoglicemia e seus fatores de risco na infusão contínua de insulina em pacientes críticos]]></article-title>
<article-title xml:lang="es"><![CDATA[Hipoglucemia y sus factores de riesgo en la administración continua de insulina en pacientes críticos]]></article-title>
<article-title xml:lang="en"><![CDATA[Hypoglycemia and Associated Risk Factors during Continuous Insulin Administration in Critically-ill Patients]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Magalhães de Azeredo Granadeiro]]></surname>
<given-names><![CDATA[Raquel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vianna Alóchio]]></surname>
<given-names><![CDATA[Kyra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Chaves Sá]]></surname>
<given-names><![CDATA[Selma Petra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro Universitário Augusto Motta  ]]></institution>
<addr-line><![CDATA[Rio de Janeiro RJ]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidade Federal Fluminense  ]]></institution>
<addr-line><![CDATA[Niterói RJ]]></addr-line>
<country>Brazil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2019</year>
</pub-date>
<volume>35</volume>
<numero>3</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-03192019000300016&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-03192019000300016&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-03192019000300016&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução: A hipoglicemia é o efeito adverso mais importante em pacientes submetidos a terapia com insulina intravenosa na unidade de terapia intensiva, devido ao seu difícil controle pelos profissionais de saúde, sendo também associado a outros fatores de risco clínicos e patológicos.  Objetivo: Identificar na literatura os fatores de risco de hipoglicemia durante a infusão contínua de insulina intravenosa.  Métodos: Estudo de revisão de literatura integrativa. A coleta de dados foi realizada através do acesso aos bancos de dados pertencentes à Biblioteca Virtual em Saúde (BVS), LILACS, MEDLINE, BDENF e PUBMED, durante o período de março a abril de 2017, o que resultou na Seleção de 11 estudos do processo de revisão.  Conclusão: Fatores de risco para hipoglicemia durante infusão contínua de insulina: objetivo glicêmico rigoroso, suporte nutricional inadequado ou descontinuado, diabetes, falência orgânica, insuficiência renal aguda e crônica, hemodiálise, falta de padronização do trajeto de medição de glicemia, sepse, medicamentos vasoativos, atrasos nas medidas de glicose no sangue, ajustes inadequados no protocolo de insulina venosa, intervalos de verificação de insulina em 2h ou 4h, influência da hemoglobina glicosilada (HbA1c), doença hepática e dificuldades de aplicação e continuidade de Protocolos de monitoramento glicêmico e infusões. Assim, os profissionais que estão diretamente envolvidos com a terapia acima mencionada e o atendimento ao paciente assistido podem definir comportamentos que minimizam a ocorrência de hipoglicemia e óbitos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  La hipoglucemia es el efecto adverso más importante en los pacientes sometidos a la terapia de insulina endovenosa en la unidad de cuidados intensivos, por razón de su difícil control por los profesionales de salud, siendo también asociada a otros factores clínicos y patológicos de riesgo.  Objetivo:  Identificar en la literatura los factores de riesgo para la hipoglucemia durante la administración continua de insulina endovenosa.  Métodos:  Estudio de revisión integradora de la literatura. La recopilación de datos se llevó a cabo mediante el acceso a las bases de datos pertenecientes a la Biblioteca Virtual de Salud (BVS), LILACS, MEDLINE, BDENF y PUBMED, durante el período de marzo a abril de 2017, lo que resultó en la selección de 11 estudios a partir del proceso de revisión.  Conclusión: Son factores de riesgo para hipoglucemia durante la infusión continua de insulina: objetivo glucémico riguroso, soporte nutricional inadecuado o descontinuado, diabetes, falencia orgánica, insuficiencia renal aguda y crónica, hemodiálisis, falta de estandarización de la vía de medición de la glucemia, sepsis, drogas vasoactivas, retrasos en las mediciones de la glucemia, ajustes inadecuados en el protocolo de insulina venosa, intervalos de verificación de insulina en 2h o 4h, influencia de la hemoglobina glicosilada (HbA1c), enfermedad hepática y las dificultades de aplicación y continuidad de los protocolos de vigilancia glucémica e infusiones. Siendo así, los profesionales que están directamente involucrados con la terapia mencionada y con la atención del paciente asistido podrán definir conductas que minimicen la ocurrencia de hipoglucemias y defunciones.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Hypoglycemia is the most important adverse effect in patients undergoing intravenous insulin therapy in the intensive care unit, due to its difficult control by health professionals, also being associated with other clinical and pathological risk factors.  Objective:  To identify in the literature the risk factors for hypoglycemia during the continuous administration of intravenous insulin.  Methods:  Integrative review study of the literature. Data collection was carried out by accessing the databases belonging to the Virtual Health Library (VHL), LILACS, MEDLINE, BDENF, and PUBMED, during the period from March to April 2017, which resulted in the selection of 11 studies after the review process.  Conclusion:  Risk factors for hypoglycemia during continuous insulin infusion are rigorous glycemic objective, inadequate or discontinued nutritional support, diabetes, organic failure, acute and chronic renal failure, hemodialysis, lack of standardization of the blood glucose measurement pathway, sepsis, vasoactive drugs, delays in blood glucose measurements, inadequate adjustments in the venous insulin protocol, 2-4h insulin verification intervals, influence of glycosylated hemoglobin (HbA1c), liver disease, and difficulties in application and continuity of glycemic surveillance protocols and infusions. Thus, professionals who are directly involved with the aforementioned therapy and with the care for the assisted patient can define behaviors that minimize the occurrence of hypoglycemia and deaths.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Insulina]]></kwd>
<kwd lng="pt"><![CDATA[unidades de cuidados intensivos]]></kwd>
<kwd lng="pt"><![CDATA[hipoglicemia]]></kwd>
<kwd lng="pt"><![CDATA[fatores de risco]]></kwd>
<kwd lng="es"><![CDATA[Insulina]]></kwd>
<kwd lng="es"><![CDATA[unidades de cuidados intensivos]]></kwd>
<kwd lng="es"><![CDATA[hipoglucemia]]></kwd>
<kwd lng="es"><![CDATA[factores de riesgo]]></kwd>
<kwd lng="en"><![CDATA[insulin]]></kwd>
<kwd lng="en"><![CDATA[intensive care units]]></kwd>
<kwd lng="en"><![CDATA[hypoglycemia]]></kwd>
<kwd lng="en"><![CDATA[risk factors]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Umpierrez]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
<name>
<surname><![CDATA[Isaacs]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Bazargan]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[You]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Thaler]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Kitabchi]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes]]></article-title>
<source><![CDATA[J Clin Endocrinol Metab]]></source>
<year>2002</year>
<volume>87</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>978-82</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pasquel]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Umpierrez]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manejo de lahiperglucemia em el paciente hospitalizado]]></article-title>
<source><![CDATA[Medicina (B. Aires)]]></source>
<year>2010</year>
<volume>70</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>275-83</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lazzari]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Volkart]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Eficiência da solução de insulina: comparação entre diferentes tempos de manutenção da solução]]></article-title>
<source><![CDATA[Rev bras ter intensiva]]></source>
<year>2010</year>
<volume>22</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>358-62</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van]]></surname>
<given-names><![CDATA[DBG]]></given-names>
</name>
<name>
<surname><![CDATA[Wouters]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Weekers]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Verwaest]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bruyninckx]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Schetz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intensive insulin therapy in the critically ill patients]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2001</year>
<volume>345</volume>
<numero>19</numero>
<issue>19</issue>
<page-range>1359-67</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van]]></surname>
<given-names><![CDATA[DBG]]></given-names>
</name>
<name>
<surname><![CDATA[Wilmer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hermans]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Meersseman]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Wouters]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Milants]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intensive insulin therapy in the medical ICU]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2006</year>
<volume>354</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>449-61</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[WO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Controle glicêmico em pacientes críticos na UTI]]></article-title>
<source><![CDATA[Revista Hospital Universitário Pedro Ernesto]]></source>
<year>2013</year>
<volume>12</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>47-56</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Egi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bello]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Stachawski]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[French]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hart]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Stow]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intensive insulin therapy in postoperative intensive care unit patients: a decision analysis]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2006</year>
<volume>173</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>407-13</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>Sociedade Brasileira de Diabetes (SBD)</collab>
<source><![CDATA[Controle da Glicemia em paciente hospitalizado. Posicionamento Oficial SBD nº 03/2015]]></source>
<year>2015</year>
<publisher-loc><![CDATA[São Paulo (SP) ]]></publisher-loc>
<publisher-name><![CDATA[SBD]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gomes]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Foss]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Foss-Freitas]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Controle da Hiperglicemia intra-hospitalar em pacientes Críticos e não-críticos]]></article-title>
<source><![CDATA[Medicina (Ribeirão Preto)]]></source>
<year>2014</year>
<volume>47</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>194-200</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paixão]]></surname>
<given-names><![CDATA[CT]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[LD]]></given-names>
</name>
<name>
<surname><![CDATA[Nepuceno]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[KBS]]></given-names>
</name>
<name>
<surname><![CDATA[Almeida]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Controle Glicêmico em pacientes críticos que recebem insulina: revisão integrativa]]></article-title>
<source><![CDATA[Rev pesqui cuid fundam]]></source>
<year>2015</year>
<volume>7</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>3339-50</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Bonito]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
<name>
<surname><![CDATA[Tomlinson]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[FL]]></given-names>
</name>
<name>
<surname><![CDATA[Homlok]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Noémi]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safety, efficacy and clinical generalization of the STAR protocol: a retrospective analysis]]></article-title>
<source><![CDATA[Ann Intensive Care]]></source>
<year>2016</year>
<volume>6</volume>
<page-range>24</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Corrêa]]></surname>
<given-names><![CDATA[TD]]></given-names>
</name>
<name>
<surname><![CDATA[Almeida]]></surname>
<given-names><![CDATA[FP]]></given-names>
</name>
<name>
<surname><![CDATA[Cavalcanti]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Avaliação da percepção de enfermeiros sobre três protocolos para controle glicêmico em pacientes críticos]]></article-title>
<source><![CDATA[Einstein (São Paulo)]]></source>
<year>2012</year>
<volume>10</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>347-53</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boutin]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Gauthier]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Insulin infusion therapy in critically ill patients]]></article-title>
<source><![CDATA[Can J Diabetes]]></source>
<year>2014</year>
<volume>38</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>144-50</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Botelho]]></surname>
<given-names><![CDATA[LLR]]></given-names>
</name>
<name>
<surname><![CDATA[Cunha]]></surname>
<given-names><![CDATA[CCA]]></given-names>
</name>
<name>
<surname><![CDATA[Macedo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[O método de revisão integrativa nos estudos organizacionais]]></article-title>
<source><![CDATA[Gestão e Sociedade]]></source>
<year>2011</year>
<volume>5</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>121-36</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[CMC]]></given-names>
</name>
<name>
<surname><![CDATA[Pimenta]]></surname>
<given-names><![CDATA[CAM]]></given-names>
</name>
<name>
<surname><![CDATA[Nobre]]></surname>
<given-names><![CDATA[MRC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências]]></article-title>
<source><![CDATA[Latino-Am Enfermagem]]></source>
<year>2007</year>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>508-11</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Souza]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Revisão integrativa: o que é e como fazer]]></article-title>
<source><![CDATA[Einstein (São Paulo)]]></source>
<year>2010</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>102-6</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pompeo]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Rossi]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Galvão]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Revisão integrativa:etapa inicial do processo de validação de diagnóstico de enfermagem]]></article-title>
<source><![CDATA[Acta Paul Enferm]]></source>
<year>2009</year>
<volume>22</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>434</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bilotta]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Rosa]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glycemia management in critical care patients]]></article-title>
<source><![CDATA[Word Journal of Diabetes]]></source>
<year>2012</year>
<volume>3</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>130-4</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perez]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Varga]]></surname>
<given-names><![CDATA[LI]]></given-names>
</name>
<name>
<surname><![CDATA[Rose]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gaughan]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of the efficacy and safety of two different insulin infusion protocols in the medical intensive care unit]]></article-title>
<source><![CDATA[Hosp Pharm]]></source>
<year>2013</year>
<volume>48</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>213-8</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Honiden]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Inzucchi]]></surname>
<given-names><![CDATA[SI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic management during critical illness: glycemic control in the ICU]]></article-title>
<source><![CDATA[Semin Respir Crit Care Med]]></source>
<year>2015</year>
<volume>36</volume>
<numero>06</numero>
<issue>06</issue>
<page-range>859-69</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paixão]]></surname>
<given-names><![CDATA[CT]]></given-names>
</name>
<name>
<surname><![CDATA[Nepomuceno]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[LD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fatores predisponentes para hipoglicemia: aumentando a segurança do paciente crítico]]></article-title>
<source><![CDATA[Revenferm UERJ]]></source>
<year>2015</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>70-5</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mahmoodpoor]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hamishhkar]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Beigmohammadi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sarvin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Shadvar]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Soleimanpour]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Rahimi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Safari]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predisposing factores for hypoglycemia and its relation with mortality in criticallyill patients undergoing insulin therapy in intensive care unit]]></article-title>
<source><![CDATA[Anesth Pain Med]]></source>
<year>2016</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marvin]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Inzucchi]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Besterman]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Minimization of hypoglycemia as an adverse event during insulin infusion: further refinement of the Yale protocol]]></article-title>
<source><![CDATA[Diabetes Technol Ther]]></source>
<year>2016</year>
<volume>18</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>480-6</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marvin]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Inzucchi]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Besterman]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Computerization of the Yale insulin infusion protocol and potential insights into causes of hypoglycemia with intravenous insulin]]></article-title>
<source><![CDATA[Diabetes Technol Ther]]></source>
<year>2013</year>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>246-52</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paixão]]></surname>
<given-names><![CDATA[CT]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[LD]]></given-names>
</name>
<name>
<surname><![CDATA[Doerzapff]]></surname>
<given-names><![CDATA[PB]]></given-names>
</name>
<name>
<surname><![CDATA[Granadeiro]]></surname>
<given-names><![CDATA[RMA]]></given-names>
</name>
<name>
<surname><![CDATA[Farias]]></surname>
<given-names><![CDATA[RLA]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fatores de risco para hipoglicemia em pacientes críticos que usam infusão contínua de insulina endovenosa na unidade de terapia intensiva]]></article-title>
<source><![CDATA[ABCS Health Sci]]></source>
<year>2014</year>
<volume>39</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>194-8</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sandler]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Misiasz]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Baldwin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reducing the risk of hypoglycemia associated with intravenous insulin: experience with a computerized insulin infusion program in 4 adult intensive care units]]></article-title>
<source><![CDATA[J Diabetes Sci Technol]]></source>
<year>2014</year>
<volume>8</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>923-9</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torreda]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano]]></surname>
<given-names><![CDATA[CdL]]></given-names>
</name>
<name>
<surname><![CDATA[Solsona]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Ibars]]></surname>
<given-names><![CDATA[RMC]]></given-names>
</name>
<name>
<surname><![CDATA[Arfelis]]></surname>
<given-names><![CDATA[JMN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Control Glucémico em el enfermo crítico: comparación de dos protocolos de insulinización intravenosa]]></article-title>
<source><![CDATA[Clin Med]]></source>
<year>2014</year>
<volume>142</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>192-9</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kauffmann]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Hayes]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Vanlaeken]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Norris]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Maio]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Collier]]></surname>
<given-names><![CDATA[Bryan]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hypocaloric enteral nutrition protects against hypoglycemia associated with intensive insulin therapy better than intravenous dextrose]]></article-title>
<source><![CDATA[Am Surg]]></source>
<year>2014</year>
<volume>80</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1106-11</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
